Spotlight Medical is a French oncology diagnostics company developing evidence-driven, clinical-grade artificial intelligence (AI) tests to support more precise treatment selection in cancer. The company creates personalized clinical tests that optimize therapy choices for individual patients, aiming to improve outcomes by avoiding the pitfalls of generic treatment plans. By leveraging AI-powered pathology assays, Spotlight Medical enables clinicians to make more informed decisions, particularly in complex cases such as early ER+/HER2- breast cancer, where it has validated a low-risk subgroup within clinically high-risk patients.